2023 HFSA - Improving Outcomes with SGLT2 Inhibitors in Patients with Heart Failure: From Evidence to Clinical Practice - Free CME/CE Courses for Healthcare Professionals

Event: '2023 HFSA - Improving Outcomes with SGLT2 Inhibitors in Patients with Heart Failure: From Evidence to Clinical Practice'

	CME Satellite Symposium	Date: Saturday, October 07, 2023 (07:15 AM-08:45 AM) Duration: 1 Hour(s) 30 Minute(s)
		URL: hfsa.org/asm/hfsa-annual-scientific-meeting-2023
		Location: Huntington Convention Center, Cleveland, Ohio

CHAIR Muthiah Vaduganathan, MD, MPH Co-Director, Center for Cardiometabolic Implementation Science Brigham and Women's Hospital Harvard Medical School Boston, Massachusetts FACULTY Stephen Greene, MD Assistant Professor Division of Cardiology Duke University Medical Center/Duke Clinical Research Institute Durham, North Carolina Mikhail Kosiborod, MD Vice President of Research Saint Luke's Health System Professor of Medicine University of Missouri-Kansas City Kansas City, Missour Alanna Morris, MD, MSc Associate Professor of Medicine Director of Heart Failure Research Emory University Clinical Cardiovascular Research Institute Atlanta, Georgia Voxmedia LLC gratefully acknowledges the educational grant provided by AstraZeneca Pharmaceuticals. Pre-registration is for planning purposes only and does not guarantee seating. For additional CME/CE activities visit www.CMEPlanet.com #HFSA2023 #SGLT2 #heartfailure